ENTA Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc is a biotechnology company. It is engaged in the research and development of small molecule drugs for infectious diseases. The Company uses its chemistry-driven approach & drug discovery capabilities to develop its products.

$47.28  +0.37 (0.79%)
As of 06/30/2022 15:59:59 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/21/2013
Outstanding shares:  20,712,691
Average volume:  297,109
Market cap:   $971,632,335
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B9L5200

---

Valuation   (See tab for details)

---

PE ratio:   -8.65
PB ratio:   2.70
PS ratio:   10.08
Return on equity:   -31.33%
Net income %:   -122.68%